ArticleArtificial organs2025
CFD-Based Hemolysis Study of Fontan Cavopulmonary Assist Device Using Kriging Surrogate Modeling.
Article in Artificial organs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Early Models to Emerging Trends: The Evolution of Computational Hemolysis Prediction.Annals of biomedical engineering · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPredicting hemolysis numerically based on the power-law model using idealized coefficients obtained from simplified devices yields a large variability in hemolysis index predictions. A computational fluid dynamics (CFD)-based Kriging surrogate modeling approach, developed by Craven et al. at the US Food & Drug Administration (FDA), was applied to a Fontan cavopulmonary assist device (CPAD) to generate device-specific hemolysis power-law coefficients.
methodsThe hemolysis index of a CPAD was measured using tests in a mock loop and simulated using CFD. The Kriging surrogate modeling approach was employed for the Lagrangian and Eulerian formulations of the stress-based hemolysis power-law model. The CPAD-specific power-law coefficients obtained from one design of the CPAD were used in predicting the Modified Index of Hemolysis (MIH) for an alternate design of the CPAD.
resultsThe MIH CFD predictions with the CPAD-specific coefficients deviate by 16%-20% using the Eulerian approach, and 7%-15% using the Lagrangian approach, compared with experimental results for the alternate design. This vastly improves over the use of idealized empirical coefficients, which yield variation in MIH predictions up to two orders of magnitude.
conclusionThe presented power-law approach shows good correlation between CFD and tests in predicting MIH for CPAD design modifications. The hemolysis power-law coefficients obtained in this study may be useful in predicting hemolysis in similar rotary blood pumps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.